Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Retained Earnings: 2024

Historic Retained Earnings for Kura Oncology (KURA) over the last 1 years, with Dec 2024 value amounting to -$895.4 million.

  • Kura Oncology's Retained Earnings fell 24.75% to -$1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.1 billion, marking a year-over-year decrease of 24.75%. This contributed to the annual value of -$895.4 million for FY2024, which is N/A change from last year.
  • Kura Oncology's Retained Earnings amounted to -$895.4 million in FY2024.
  • Kura Oncology's Retained Earnings' 5-year high stood at -$895.4 million during FY2024, with a 5-year trough of -$895.4 million in FY2024.
  • Over the past 1 years, Kura Oncology's median Retained Earnings value was -$895.4 million (recorded in 2024), while the average stood at -$895.4 million.